Archive for the ‘disorder’ tag
New Geodon HCP campaign
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009
To see all of this brand’s ads on AdPharm, click here
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Lexapro
For the core symptoms of Major Depressive Disorder (MDD) & Generalized Anxiety Disorder (GAD) in adults
See the effect of Lexapro
Proven efficacy in MDD and GAD
Depressed Mood – Tension – Anxiety
[FLASH]Now FDA approved for MDD in adolescents aged 12 to 17
Escitalopram (trade names Lexapro, Cipralex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder and generalized anxiety disorder in adults; other indications include social anxiety disorder, panic disorder and obsessive-compulsive disorder. Escitalopram is the S-stereoisomer (enantiomer) of the earlier Lundbeck drug citalopram (Celexa), hence the name escitalopram. Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and, as a result has fewer side effects not related to its serotonergic activity. According to a meta-analysis of 12 new-generation antidepressants, escitalopram and sertraline (Zoloft) are the best in terms of efficacy and acceptability in the acute-phase treatment of adults with major depression; however, sertraline may be a better choice because of the lower cost.
Brand name: Lexapro
Generic name/category: Escitalopram, Selective serotonin reuptake inhibitors (SSRI)
Company: Forest pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: two-page
Publication/Aired: Managed Healthcare Executive – August 2009
To see all of this brand’s ads on AdPharm, click here
4 views
Sep 05, 2009
Visit AdPharm.net for more pharmaceutical ads
Sarafem for PMDD from 2001
irritABILITY
Think it’s PMS? Think again.
It could be PMDD.
Fluoxetine (trade name Prozac) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Fluoxetine is approved for the treatment of major depression (including pediatric depression), obsessive-compulsive disorder (in both adult and pediatric populations), bulimia nervosa, anorexia nervosa, panic disorder and premenstrual dysphoric disorder. Despite the availability of newer agents, it remains extremely popular. Over 22.2 million prescriptions for generic formulations of fluoxetine were filled in the United States in 2007, making it the third most prescribed antidepressant.
Eli Lilly’s patent on Prozac (fluoxetine) expired in August, 2001, prompting an influx of generic drugs onto the market. Prozac was rebranded “Sarafem” for the treatment PMDD in an attempt to stem the post-patent decrease in Eli Lilly’s sales of fluoxetine.
Brand name: Sarafem
Generic name/category: Fluoxetine, selective serotonin reuptake inhibitor (SSRI)
Company: Lilly
Country/Market: USA, North America
Indication(s)/use: Premenstrual Dysphoric Disorder (PMDD)
Target: Consumers (DTC)
Tagline: More like the woman you are
Medium: Print ad
Size/duration: single-page
Publication/Aired: Ebony – February 2001
Geodon
Control acute agitation with Geodon for injection
In schizophrenia… Rapid improvement with low EPS
Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain FDA approval (February 2001). In the United States, Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania and mixed states associated with bipolar disorder. The brand name Geodon has been suggested to bring to mind the phrase 'down (don) to earth (geo)' referring to the goals of the medication.
The oral form of ziprasidone is the hydrochloride salt, ziprasidone hydrochloride. The intramuscular form, on the other hand, is the mesylate salt, ziprasidone mesylate trihydrate, and is provided as a lyophilized powder.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotics
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
2 views
Aug 23, 2009
Visit AdPharm.net for more pharmaceutical ads
Geodon
Control acute agitation with Geodon for injection
In schizophrenia… Rapid improvement with low EPS
Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain FDA approval (February 2001). In the United States, Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania and mixed states associated with bipolar disorder. The brand name Geodon has been suggested to bring to mind the phrase 'down (don) to earth (geo)' referring to the goals of the medication.
The oral form of ziprasidone is the hydrochloride salt, ziprasidone hydrochloride. The intramuscular form, on the other hand, is the mesylate salt, ziprasidone mesylate trihydrate, and is provided as a lyophilized powder.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotics
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009
